Singular Genomics Systems, Inc.
NASDAQ:OMIC
23.3 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 16.233 | 74.266 | 201.049 | 11.688 | 5.5 |
| Short Term Investments
| 157.708 | 170.31 | 138.174 | 15.231 | 40.696 |
| Cash and Short Term Investments
| 173.941 | 244.576 | 339.223 | 26.919 | 46.196 |
| Net Receivables
| 1.584 | 2.012 | 1.05 | 0.017 | 0 |
| Inventory
| 13.572 | 18.221 | 3.011 | -0.017 | 0 |
| Other Current Assets
| 1.459 | 0.62 | 0.761 | 0.652 | 0.261 |
| Total Current Assets
| 192.228 | 268.432 | 347.76 | 27.571 | 46.457 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 71.489 | 56.68 | 6.072 | 2.368 | 1.613 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| -16.323 | -14.863 | 0 | 0 | 0 |
| Long Term Investments
| 0.6 | 1.711 | 0.687 | 0.482 | 0.023 |
| Tax Assets
| 15.723 | 13.152 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.75 | 2.863 | 1.129 | 0.081 | 0.081 |
| Total Non-Current Assets
| 73.239 | 59.543 | 7.888 | 2.931 | 1.717 |
| Total Assets
| 265.467 | 327.975 | 355.648 | 30.502 | 48.174 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.587 | 3.099 | 2.348 | 0.427 | 0.561 |
| Short Term Debt
| 7.764 | 6.323 | 0 | 0.926 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 6.079 | 4.583 | 0 | 1.592 | 0 |
| Other Current Liabilities
| 1.857 | 0.113 | 4.396 | 0.745 | 0.551 |
| Total Current Liabilities
| 18.287 | 14.118 | 6.744 | 3.69 | 1.112 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 67.524 | 52.521 | 9.904 | 8.469 | 2.4 |
| Deferred Revenue Non-Current
| 0.3 | 0.1 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 15.723 | 13.152 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -15.373 | -12.237 | 2.827 | 69.898 | 69.387 |
| Total Non-Current Liabilities
| 68.174 | 53.536 | 12.731 | 78.367 | 71.787 |
| Total Liabilities
| 86.461 | 67.654 | 19.475 | 82.057 | 72.899 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 355.648 | 69.184 | 69.214 |
| Common Stock
| 0.007 | 0.007 | 0.007 | 0.001 | 0.001 |
| Retained Earnings
| -337.595 | -242.775 | -151.896 | -53.125 | -25.18 |
| Accumulated Other Comprehensive Income/Loss
| 0.155 | -0.837 | -0.138 | 0.017 | 0.014 |
| Other Total Stockholders Equity
| 516.439 | 503.926 | 132.552 | -67.632 | -68.774 |
| Total Shareholders Equity
| 179.006 | 260.321 | 336.173 | -51.555 | -24.725 |
| Total Equity
| 179.006 | 260.321 | 336.173 | -51.555 | -24.725 |
| Total Liabilities & Shareholders Equity
| 265.467 | 327.975 | 355.648 | 30.502 | 48.174 |